TUXEDO-India: Paclitaxel Stent Flops vs 'Limus' Even in DiabeticsTUXEDO-India: Paclitaxel Stent Flops vs 'Limus' Even in Diabetics

Confirmation that paclitaxel coronary stents, as it happens, aren't more effective in diabetics than those eluting everolimus also reinforces doubts about trials favoring CABG in diabetics, say some. Heartwire from Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news